RE
DTIL icon

RBC Europe’s Precision BioSciences DTIL Stock Holding History

RBC Europe’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed -$3.47K – 761
2021
Q3 		$3.47K Hold
10
– – ﹤0.01% 1079
2021
Q2 		$3.77K Hold
10
– – ﹤0.01% 1066
2021
Q1 		$3.12K Hold
10
– – ﹤0.01% 1039
2020
Q4 		$2.51K Hold
10
– – ﹤0.01% 1033
2020
Q3 		$1.85K Hold
10
– – ﹤0.01% 992
2020
Q2 		$2.51K Hold
10
– – ﹤0.01% 937
2020
Q1 		$1.81K Buy
+10
New +$2.62K ﹤0.01% 926

Other funds holding DTIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RBC Europe's DTIL Position: Q4 2021 in Review

RBC Europe sold out of Precision BioSciences (DTIL) in Q4 2021, closing a stake of 10 shares — an estimated $3.47K sold.

RBC Europe first reported a position in DTIL in Q1 2020 and held it in 7 quarters. The position peaked at $3.77K in Q2 2021. 134 funds tracked by Wall St. Rank hold DTIL as of Q4 2021.

  • RBC Europe reported no remaining Precision BioSciences position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 10 Precision BioSciences shares in Q4 2021, an estimated $3.47K.
  • RBC Europe first reported a position in Precision BioSciences in Q1 2020 and held it in 7 quarters.
  • RBC Europe's Precision BioSciences position peaked at $3.77K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.